Mark W. Lotz
Keine laufenden Positionen mehr
Profil
Mark W.
Lotz held several regulatory affairs positions in the pharmaceutical industry, including Senior Director at Elan Pharmaceuticals, Head of Regulatory and Quality Assurance at Amylin Pharmaceuticals and Ionis Pharmaceuticals, and Vice President of Regulatory Affairs at Xencor, IASO Pharma, and Vital Therapies.
He also served as Principal at Abbott Laboratories.
Lotz received his undergraduate degree from St. Louis College of Pharmacy.
Ehemalige bekannte Positionen von Mark W. Lotz
| Unternehmen | Position | Ende |
|---|---|---|
| XENCOR, INC. | General Counsel | 01.08.2019 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | General Counsel | 01.04.2007 |
| MEDICINOVA, INC. | General Counsel | 01.05.2005 |
| IASO PHARMA INC | General Counsel | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Ausbildung von Mark W. Lotz
| St. Louis College of Pharmacy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| MEDICINOVA, INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
IASO Pharma, Inc.
 IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology IASO Pharma, Inc. operated as a development stage biopharmaceutical company which focused on acquiring, developing and commercializing drugs for the treatment and prevention of infectious diseases and other serious illnesses. The company was founded on October 5, 2006 and is headquartered in San Diego, CA. | Health Technology |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
